GlaxoSmithKline welcomes innovative knowledge-sharing collaboration to break deadlock in antibiotic discovery and development
17 November 2011 | By GlaxoSmithKline
GSK welcomes the EC’s commitment...
List view / Grid view
17 November 2011 | By GlaxoSmithKline
GSK welcomes the EC’s commitment...
17 November 2011 | By GlaxoSmithKline
GSK welcomed the decision of the GAVI...
17 November 2011 | By Eli Lilly and Company
Eli Lilly and Company is providing more than $4 million in additional funding...
17 November 2011 | By kdm communications limited
The fourth annual Tecan Symposium, welcomed leading genomics, proteomics & biobanking experts from around the globe...
17 November 2011 | By Novartis
Discovery of a new class of dual-acting antimalarial compounds...
16 November 2011 | By GlaxoSmithKline
GlaxoSmithKline announced that topline results have been received...
16 November 2011 | By kdm communications limited
Syrris, is pleased to be a sponsor of the 1st Flow Chemistry Symposium (1st FCS)...
16 November 2011 | By Eli Lilly and Company
An analysis of the TRITON-TIMI 38 trial presented...
15 November 2011 | By Amgen
The EC has approved a variation to the marketing authorization for Vectibix®...
15 November 2011 | By Abbott
Final results were presented today from the AIM-HIGH study, a National Heart, Lung and Blood Institute (NHLBI) study...
15 November 2011 | By AstraZeneca
Data presented at this year’s AHA reinforces the established efficacy profile of CRESTOR...
15 November 2011 | By Gilead Sciences
Gilead Sciences, Inc. has entered into a license agreement with Tibotec Pharmaceuticals...
14 November 2011 | By kdm communications limited
Avacta Analytical is partnering with University College London as an industrial sponsor...
14 November 2011 | By Novo Nordisk
On World Diabetes Day, new numbers on the prevalence of diabetes have been released by the IDF...
14 November 2011 | By Sanofi
The Phase lll CARE-MS ll trial met both of its co-primary endpoints...